Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-17-012254)

Filing Details

Accession Number:: 0000899243-17-012254
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-05-08 17:14:55
Reporting Period:: 2017-05-04

Filing Date:: 2017-05-08
Accepted Time:: 2017-05-08 17:14:55
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1088856	Corcept Therapeutics Inc	CORT	Pharmaceutical Preparations (2834)	770487658

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1529655	Charles Gary Robb	C/O Corcept Therapeutics Incorporated 149 Commonwealth Drive Menlo Park CA 94025	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-05-04	5,600	$9.75	6,858	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Represents the weighted average purchase price for the entire number of shares purchased. The actual purchase prices range from $9.7470 to $9.7499 per share. Detailed information on the exact number of shares purchased at each purchase price can be obtained from the issuer upon request.